Related Experiment Video
Updated: Jul 6, 2025
Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
A Call for Early Detection of Cerebral Palsy
1Department of Pediatrics, Columbia University Irving Medical Center/NewYork-Presbyterian Children's Hospital of New York, New York, NY.
Insights
Early diagnosis of cerebral palsy (CP) is now possible by 3 months in high-risk infants. Combining assessments like the General Movements Assessment and neuroimaging improves early detection and intervention opportunities.
Area of Science:
- Neurology
- Developmental Pediatrics
- Rehabilitation Medicine
Background:
- Cerebral palsy (CP) is a leading cause of lifelong physical disability.
- Historically, diagnosis was delayed until after 2 years due to diagnostic challenges and limited research on early intervention benefits.
Purpose of the Study:
- To review evidence supporting earlier diagnosis of cerebral palsy.
- To highlight the benefits of early detection and intervention in high-risk infants.
Main Methods:
- Utilized evidence-based guidelines from 2017.
- Combined General Movements Assessment, Hammersmith Infant Neurological Examination, neuroimaging, clinical history, and standardized motor assessments.
- Focused on high-risk newborns for early detection.
Main Results:
- Guidelines enable CP diagnosis as early as 3 months in high-risk newborns.
- Implementation has successfully reduced the age of CP diagnosis.
- Early detection facilitates research into interventions during critical neuroplasticity periods.
Conclusions:
- Early detection of cerebral palsy is feasible and beneficial.
- Facilitates timely interventions to improve developmental outcomes.
- Ongoing research and global initiatives focus on early detection and targeted interventions.
Abstract:
Cerebral palsy (CP) is the most common physical disability across the lifespan, but historically, CP has not been diagnosed before the age of 2 years. Barriers to early diagnosis ranged from lack of available biomarkers, absence of curative treatments, perceived stigma associated with a lifelong diagnosis, and a desire to rule out other diagnoses first. Most importantly, the fundamental question that remained was whether children would benefit from earlier detection and intervention given the paucity of research. However, evidence-based guidelines published in 2017 demonstrated that the General Movements Assessment, the Hammersmith Infant Neurological Examination, and neuroimaging can be combined with other elements such as a clinical history and standardized motor assessments to provide the highest predictive value for diagnosing CP as early as age 3 months in high-risk newborns. Implementation of these guidelines has been successful in decreasing the age at CP diagnosis, particularly in high-risk infant follow-up clinics with expertise in performing these assessments. Early detection of CP allows for clinical and research opportunities investigating earlier interventions during a critical period of neuroplasticity, with the goal of improving developmental trajectories for children and their families. New guidelines and research are now being developed with a focus on early, targeted interventions that continue to be studied, along with global detection initiatives.
